MHRA statement on investigation into Roche
MHRA have issued a statement in response the European Medicines Agency’s update on Roche’s medicine-safety reporting system.
View ArticleMHRA statement on new flu vaccination programme for children
The MHRA has issued a statement in response the Department of Health’s announcement that a new vaccination programme may be implemented in 2014 for children aged between two and 17.
View ArticleMHRA publishes supporting information into 2010 testing of PIP breast implants
The MHRA and the Department of Health have today published supporting information used in the 2010 testing of PIP breast implants. This is additional to the testing results that were announced in...
View ArticlePharmacists encouraged to report adverse drug reactions through Yellow Card...
The MHRA, NHS Employers and the Pharmaceutical Services Negotiating Committee are encouraging community pharmacists to report any adverse drug reactions through the MHRA’s Yellow Card Scheme.
View ArticleDrug safety: reporting systems for the general public
Dr June Raine, Director of Vigilance and Risk Management of Medicines at the MHRA, reports in the British Medical Journal (BMJ) on the latest guidance on monitoring the safety of drugs from the World...
View ArticleDepartment of Health launches review of cosmetic surgery and procedures
A major review of cosmetic surgery and procedures has been launched by the Department of Health.
View ArticleMHRA publishes interim-report about 2012 testing of PIP breast implants
The MHRA and the Department of Health have today published an interim-report of this year’s ongoing testing of PIP breast implants.
View ArticleMHRA repeats warning for people not to use unlicensed tanning drug melanotan
The MHRA has repeated its warning not to use the unlicensed tanning drug malanotan.
View ArticleLearning package on antipsychotics launched
The MHRA have today launched a learning module on antipsychotics for clinical practitioners. The self-directed learning package outlines the key risks of this widely prescribed class of medicines.
View ArticleMHRA looking to appoint five members to the Independent Scientific Advisory...
Following recent expansion of the work of ISAC, the MHRA intend to appoint four new professional members and one new lay member to the Committee with effect from late 2012/early 2013.
View ArticleMHRA/NIBSC (National Institute for Biological Standards and Control) merger
On 1 April 2013 the National Institute for Biological Standards and Control (NIBSC), currently part of the Health Protection Agency (HPA), will officially become a new ‘centre’ of the Medicines and...
View ArticleApplications sought for a new chair of the Commission on Human Medicines
The Secretary of State for Health is seeking to appoint a chair of the Commission on Human Medicines (CHM)
View ArticleBetter guidance and support for NHS surgeons on vaginal tape and mesh implants
Better guidance and support for NHS surgeons on vaginal tape and mesh implants
View ArticleMHRA Christmas and New Year opening times
This story sets out the MHRA's opening hours over the festive period 2012/13.
View ArticleMHRA supports campaign to warn people about the risks of buying medicines online
The MHRA is involved in campaigns to highlight the risks of buying medicines online. A video has been created to highlight the potential consequences of buying Prescription Only Medicine from illicit...
View Article